2024
Using clinical and genetic risk factors for risk prediction of 8 cancers in the UK Biobank
Hu J, Ye Y, Zhou G, Zhao H. Using clinical and genetic risk factors for risk prediction of 8 cancers in the UK Biobank. JNCI Cancer Spectrum 2024, 8: pkae008. PMID: 38366150, PMCID: PMC10919929, DOI: 10.1093/jncics/pkae008.Peer-Reviewed Original ResearchPolygenic risk scoresUK BiobankCancer riskClinical risk factorsRisk of breast cancerRisk factorsPolygenic risk score modelHigh risk of developing cancerRisk of developing cancerLate-onset patientsRisk predictionClinical variablesHigh-risk individualsCox proportional hazards modelsProportional hazards modelGenetic risk factorsBaseline traitsClinical risk modelRisk scoreEarly-onset patientsHazards modelLate-onset groupEarly-onset groupBreast cancerHigh risk
2018
Body mass index and 20 specific cancers: re-analyses of dose–response meta-analyses of observational studies
Choi E, Park H, Lee K, Park J, Eisenhut M, van der Vliet H, Kim G, Shin J. Body mass index and 20 specific cancers: re-analyses of dose–response meta-analyses of observational studies. Annals Of Oncology 2018, 29: 749-757. PMID: 29300814, DOI: 10.1093/annonc/mdx819.Peer-Reviewed Original ResearchConceptsDose-response meta-analysesBody mass indexMeta-analysesMeta-analyses of observational studiesAssociation of increased BMISuggestive evidenceMass indexSummary effectsRandom-effects meta-analysesIncreased BMIRisk of developing cancerSignificance thresholdStrength of evidenceWeak evidenceUmbrella reviewCentral nervous system tumorsNon-Hodgkin's lymphomaRenal cell carcinomaNervous system tumorsObservational studyCell carcinomaProstate cancerEsophageal adenocarcinomaFixed-effectsMalignant melanoma
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply